Adoption level of artificial intelligence (AI) in Drug Discovery Worldwide (2023)
| Organization type | None (%) | Limited (%) | Occasional (%) | Substantial (%) | Extensive (%) |
|---|---|---|---|---|---|
| Academia | 33 | 23 | 13 | 27 | 3 |
| Industry | 32 | 9 | 21 | 26 | 12 |
| AI-first biotechs | 0 | 0 | 0 | 75 | 25 |
| Pharmaceutical/biotech companies | 42 | 12 | 27 | 12 | 8 |
| Organization type | None (%) | Limited (%) | Occasional (%) | Substantial (%) | Extensive (%) |
|---|---|---|---|---|---|
| Academia | 33 | 23 | 13 | 27 | 3 |
| Industry | 32 | 9 | 21 | 26 | 12 |
| AI-first biotechs | 0 | 0 | 0 | 75 | 25 |
| Pharmaceutical/biotech companies | 42 | 12 | 27 | 12 | 8 |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.